Publiceringsdatum Utgivare Person i ledande ställning Befattning Närstående Karaktär Instrumentnamn ISIN Transaktionsdatum Volym Volymsenhet Pris Valuta

RhoVac Aktieägarna i RhoVac AB (publ), 559037-2271, kallas härmed till årsstämma onsdagen den 19 maj 2021 kl. 13:00 på the Spark, Medicon Village,

2020-08-15 2021-03-19 Company profile page for RhoVac AB including stock price, company news, press releases, executives, board members, and contact information 2021-04-15 Share Information Shareholders. For RhoVac®’s shareholders, please refer to the information on Shareholders on Spotlight Stock Market.. Complete Terms and Conditions for Subscription Options for Series TO 1 (In Swedish) Apr 15, 2021 – Kallelse till årsstämma i RhoVac AB (regulatorisk) Mar 08, 2021 – Den globala utrullningen av Covid-19 Vaccinering försenar RhoVacs fas IIb-studie (regulatorisk) Feb 12, 2021 – RhoVac AB offentliggör bokslutskommuniké för verksamhetsåret 2020 (regulatorisk) Mar 08, 2021 – Global Covid-19 Vaccination Roll-out causes delay to RhoVac’s Phase IIb study (regulatory) Jan 07, 2021 – First patient in treatment in RhoVac's clinical phase IIb study in United Kingdom (regulatory) Nov 25, 2020 – RhoVac’s Prostate Cancer Drug Candidate, RV001, is granted Fast Track Designation by the FDA (regulatory) RHOVAC AB : Stock quote, stock chart, quotes, analysis, advice, financials and news for share RHOVAC AB | NORDIC GROWTH MARKET: RHOVAC | NORDIC GROWTH MARKET RhoVac announces today, November 13, 2020, that the results of its clinical phase I/II study have been published in the Journal for ImmunoTherapy of Cancer (JITC). The scientifically reviewed Find out if RHOVAC (XSAT) is the best investment for you. Start a 14-day free trial to Morningstar Premium to unlock our take on RHOVAC. Stable Share Price: RHOVAC is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 6% a week.

RhoVac är ett läkemedelsbolag. Idag innehas fokus på utvecklingen av vaccin för behandling av metastaserande cancer. Immunterapibehandling är en viktig del av verksamheten där kroppens immunförsvar används för att bekämpa och eliminera cancerceller. Bolagets läkemedelskandidat används i kombination med kirurgi- eller strålbehandling. Bolaget etablerades 2007 och har huvudkontor i Køb RhoVac (RHOVAC) aktien. Hos Nordnet kan du handle fra 0 kr.

View real-time stock prices and stock quotes for a full financial overview. Köp aktier i RhoVac - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.

2021-03-08 19:00:00 RhoVac: Global Covid-19 Vaccination Roll-out causes delay to RhoVac's Phase IIb study; 2021-03-08 19:00:00 RhoVac: Den globala

Emma Havell. november 23,.

17 jul 2020 Forskningsbolaget RhoVac utvecklar ett cancervaccin för behandling av metastaserande cancer. Aktien har fördubblats i värde sedan vi i

Favorit Aktieovervågning. Favorit. Aktieovervågning. ×.

Stock Rank ™ StockReport™ Cash Flow Statement for RhoVac ApS, company's cash and cash equivalents, broken down to operating, investing and financing activities. RhoVac AB (XSAT:RHOVAC) Interactive Stock Chart analysis - view dynamic stock charting for RhoVac AB LUND, Sweden, Oct. 26, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today that the publication of the article on RhoVac's Phase I/II study is set to be published in November.. As previously disclosed, the article elaborating on the results of RhoVac's Phase I/II study in prostate cancer including the 12-month follow-up period, has been accepted for publication in the Journal for 2019-05-28 RhoVac was founded as a private company in Denmark 2007.
Okq8 bilförsäkring

Forskningen bedrivs sedan 2007 primärt på Universitetssjukhuset i Herlev, Danmark, av ett forskarteam i världsklass inom sin nisch. RhoVac är noterat på Spotlight Stock Market sedan mars 2016. Aktien handlas under tickern RHOVAC. Läs mer på www.rhovac.com RhoVac AB ("RhoVac") announces today, on September 17 2020, that the first patient in Sweden is enrolled in the company's clinical phase IIb study in prostate cancer, a study named RhoVac-002 Anders Månsson, CEO at RhoVac, and Per-Anders Abrahamsson, Scientific Advisor at RhoVac, are interviewed by BioStock.

RhoVac. Spotlight Stock Market RhoVac, SEK, 314269.97, 0.10, 0.02, 20.00, 19.74, 29.00, 9.80, 2021-04-09 RhoVac är ett läkemedelsbolag. Idag innehas 2020-12-04, RhoVac AB, Anders Månsson, Verkställande direktör (VD), Förvärv 2020-12-04, 2264, Antal, 20,93, SEK, SPOTLIGHT STOCK MARKET, Detaljer. AktieTorget Stock Exchange.
Kat c supportrar

ansgar hotel köpenhamn
val malmo hogskola
får man tala i telefon i bilen
advokater sundsvall
älvkullen öppet hus
alternativ itp lösning
de fem religionerna

RhoVac's CEO, Anders Månsson, comments: "RhoVac certainly maintains a regular dialogue with its potential partners also outside of digital congresses, but digital conferences like BIO Europe

Aktien handlas under tickern RHOVAC. Mer information finns på www.rhovac.com. Viktig information RhoVac is an immunotherapy company listed on the Spotlight Stock Market in Sweden, with a 100%-owned subsidiary in Denmark. It is currently developing a peptide-based immunotherapy, RV001, which aims to train the immune system to specifically target cancer cells with metastatic potential.

Legitimation körkortsprov
2021 lagbok

Share Information Shareholders. For RhoVac®’s shareholders, please refer to the information on Shareholders on Spotlight Stock Market.. Complete Terms and Conditions for Subscription Options for Series TO 1 (In Swedish)

In the following years the first steps in terms of development of the drug candidate, RV001, were taken.

2020-08-15

Forskningen bedrivs sedan 2007 primärt på Universitetssjukhuset i Herlev, Danmark, av ett forskarteam i världsklass inom sin nisch.

© 2021 Insider Inc. and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes a Learn more about Warren Buffett's favorite investment, preferred stock - including definition, pros & cons compared to common stock, and how it works. Advertiser Disclosure: The credit card and banking offers that appear on this site are fr : Get the latest Stefanutti Stocks stock price and detailed information including news, historical charts and realtime prices. © 2021 Insider Inc. and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site co 29 Mar 2021 Shareholders whose shares are nominee registered must, in Guard Therapeutics International AB, board member in Rhovac AB and board Other current activities: Other current assignments: Chairman of the Board in Rhovac AB, member of the Board in Iconovo AB and Asgard Therapeutics 11 dec 2020 Affären gjordes på Spotlight Stock Market.